Colonoscopy for colorectal cancer screening saves lives, but a loophole in current Medicare law may cause patients to think twice before undergoing this vital test. Legislation introduced today seeks to ensure that colorectal cancer screening for all Medicare beneficiaries is free, as intended.
The Patient Protection and Affordable Care Act waives the coinsurance and deductible for many cancer screening testsi, including colonoscopy, sigmoidoscopy and fecal occult blood testing (FOBT), which screen for colorectal cancer. Colonoscopy is a unique screening test because gastroenterologists are able to remove precancerous polyps and small cancers during the screening procedure. Under Medicare billing rules, removal of any polyp reclassifies the screening as a therapeutic procedure, for which patients will receive an unexpected coinsurance bill.
The Removing Barriers to Colorectal Cancer Screening Act of 2012 introduced today by Rep. Charlie Dent, R-PA, waives the coinsurance for a screening colonoscopy regardless of whether a polyp or lesion is found. Under current Medicare policy, the beneficiary deductible is waived regardless of whether a polyp or lesion is found. Congressman Dent's bill applies the same rational policy to beneficiary coinsurance.
The American Cancer Society Cancer Action Network (ACS CAN), the American Gastroenterological Association (AGA) and the American Society for Gastrointestinal Endoscopy (ASGE) have been advocating for the past year and half that Congress corrects this "cost-sharing" problem, which continues to cause confusion for patients and providers.
Cost sharing creates financial barriers, which could discourage the use of colonoscopy. The Removing Barriers to Colorectal Cancer Screening Act of 2012 is critical to achieving higher screening rates and reducing the incidence of colorectal cancer. Almost 38 percent of U.S. adults age 50 and older have never been screened, despite the fact that removing precancerous polyps cuts the death rate from colorectal cancer by half.
Christopher W. Hansen, president, ACS CAN
"I commend Representative Dent for this important effort to ensure that everyone has access to life saving cancer screenings, without regard to their ability pay. Too many Americans are going without lifesaving screenings because they cannot afford it. We urge Congress to help stop a cancer that can be prevented in many cases."
Lawrence S. Kim, MD, AGAF, Community Private Practice Councillor
"The rate of colorectal cancers and deaths can be decreased through the increased use of screening. However, a majority of Americans are still not participating in these lifesaving tests. The Removing Barriers to Colorectal Cancer Screening Act of 2012 will provide consistency and security for patients seeking colorectal cancer screenings by eliminating financial barriers and removing the confusion facing patients and their physicians over the current health-care policy. The bill introduced by Rep. Dent will help us to continue to increase the strides being made in colorectal cancer screening and, most importantly, save lives."Gregory G. Ginsberg, MD, FASGE, president, American Society for Gastrointestinal Endoscopy
"Colorectal cancer is a largely preventable disease. The greatest benefit of colonoscopy screening is removing polyps that are discovered during screening and by so doing, significantly decreasing the risk for later cancer development. Converting a screening procedure that is fully covered by insurance with no cost-sharing, to one that does require cost-sharing by the patient after a polyp is found, is both a barrier to screening and inconsistent with the goal of the preventive services provision. We call upon Congress to pass this bill to fully eliminate the cost burden of colonoscopy colorectal cancer screening by waiving cost-sharing in the event that a polyp or cancer is removed."
About the American Cancer Society Cancer Action Network
ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit http://www.acscan.org.
About the American Gastroenterological Association
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org. Become an AGA fan on Facebook. Join our LinkedIn group. Follow us on Twitter @AmerGastroAssn.
About the American Society for Gastrointestinal Endoscopy
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence in gastrointestinal endoscopy. ASGE, with nearly 12,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit http://www.asge.org and http://www.screen4coloncancer.org for more information and to find a qualified doctor in your area.
i Sec. 4104 of the "Patient Protection and Affordable Care Act" (ACA) waives the beneficiary coinsurance and deductible for covered preventive services that have a grade "A" or "B" from the U.S. Preventive Services Task Force (USPSTF). Colonoscopy, sigmoidoscopy, and fecal occult blood testing (FOBT) have all been assigned an "A" rating from the USPSTF for adults beginning at age 50 and continuing until age 75.
Sec. 4104 also requires, effective Jan. 1, 2011, the deductible for colorectal cancer screenings be waived for Medicare beneficiaries regardless of the code that is billed for the establishment of a diagnosis as a result of the test, of for the removal of tissue or other matter or other procedure that is furnished in connection with, as a result of, and in the same clinical encounter as a screening test.
Jessica Duncan | EurekAlert!
Further reports about: > AGA > ASGE > Cancer > Colonoscopy > Gastrointestinal > Gastrointestinal Endoscopy > Legislation > Medicare > Removing > Screening > blood test > cancer screening > cancerous polyps > colorectal > colorectal cancer > colorectal cancer screening > educational program > endoscopy > precancerous polyps > rectal cancer > screening test
Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
18.10.2017 | Materials Sciences
18.10.2017 | Physics and Astronomy
18.10.2017 | Physics and Astronomy